CATENA, Cristiana
 Distribuzione geografica
Continente #
NA - Nord America 20.996
AS - Asia 9.134
EU - Europa 6.896
SA - Sud America 1.755
AF - Africa 211
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 13
Totale 39.035
Nazione #
US - Stati Uniti d'America 20.690
SG - Singapore 4.345
CN - Cina 1.866
UA - Ucraina 1.849
BR - Brasile 1.375
IT - Italia 1.183
DE - Germania 1.106
HK - Hong Kong 969
FI - Finlandia 801
VN - Vietnam 594
RU - Federazione Russa 484
FR - Francia 385
IE - Irlanda 314
IN - India 245
TR - Turchia 236
SE - Svezia 215
BD - Bangladesh 194
GB - Regno Unito 187
CA - Canada 174
AR - Argentina 155
KR - Corea 138
IQ - Iraq 83
MX - Messico 73
JP - Giappone 67
PK - Pakistan 64
NL - Olanda 63
ZA - Sudafrica 59
CO - Colombia 55
BE - Belgio 54
ID - Indonesia 51
EC - Ecuador 50
AT - Austria 48
PL - Polonia 44
ES - Italia 43
SA - Arabia Saudita 36
UZ - Uzbekistan 36
VE - Venezuela 34
MA - Marocco 30
CZ - Repubblica Ceca 27
CL - Cile 23
JO - Giordania 22
EU - Europa 21
MY - Malesia 21
EG - Egitto 20
PY - Paraguay 19
PE - Perù 18
IR - Iran 17
KE - Kenya 16
LB - Libano 16
TN - Tunisia 16
PH - Filippine 15
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
NP - Nepal 13
AU - Australia 12
CR - Costa Rica 11
DZ - Algeria 11
IL - Israele 11
OM - Oman 11
RS - Serbia 11
AZ - Azerbaigian 10
ET - Etiopia 10
JM - Giamaica 10
BO - Bolivia 9
KZ - Kazakistan 9
TG - Togo 9
CH - Svizzera 8
XK - ???statistics.table.value.countryCode.XK??? 8
AL - Albania 7
LT - Lituania 7
SK - Slovacchia (Repubblica Slovacca) 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
EE - Estonia 6
PA - Panama 6
PS - Palestinian Territory 6
PT - Portogallo 6
RO - Romania 6
SN - Senegal 6
AM - Armenia 5
DO - Repubblica Dominicana 5
KH - Cambogia 5
BW - Botswana 4
DK - Danimarca 4
GR - Grecia 4
HU - Ungheria 4
KG - Kirghizistan 4
RE - Reunion 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
CY - Cipro 3
GY - Guiana 3
HN - Honduras 3
HR - Croazia 3
MU - Mauritius 3
NO - Norvegia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
ZW - Zimbabwe 3
Totale 38.972
Città #
Woodbridge 2.091
Singapore 1.873
Fairfield 1.830
Ashburn 1.538
Ann Arbor 1.475
Jacksonville 1.307
Houston 1.130
Chandler 975
Hong Kong 963
San Jose 904
Beijing 863
Dearborn 788
Wilmington 783
Seattle 727
Cambridge 648
Boardman 455
Council Bluffs 342
Princeton 338
Dublin 311
Lauterbourg 309
Munich 270
Los Angeles 249
Helsinki 205
Buffalo 189
Udine 183
Izmir 163
Dallas 153
Hefei 150
Ho Chi Minh City 148
New York 130
San Diego 129
Santa Clara 129
Hanoi 125
Seoul 124
São Paulo 109
Redondo Beach 96
Milan 94
The Dalles 88
Ottawa 79
Des Moines 78
Pittsburgh 76
Ogden 71
Orem 68
Norwalk 65
Tokyo 58
Dong Ket 53
Frankfurt am Main 53
Rome 53
Nanjing 51
Mumbai 50
Kunming 49
Redmond 47
Rio de Janeiro 45
San Mateo 45
Warsaw 43
Guangzhou 42
Brooklyn 41
Atlanta 40
Brussels 40
Nuremberg 39
Denver 35
Baghdad 34
Belo Horizonte 33
Johannesburg 33
Phoenix 33
London 32
Manchester 32
Chennai 31
Chicago 31
Stockholm 31
Tashkent 31
Amsterdam 30
Brasília 29
Montreal 29
Boston 28
Shanghai 28
Vienna 26
Grafing 25
Da Nang 24
Falls Church 24
San Francisco 24
Trieste 24
Dhaka 23
Haiphong 23
Brno 22
Mexico City 22
Turku 22
Ankara 21
Washington 21
Düsseldorf 20
Jinan 20
New Delhi 20
Toronto 20
Amman 18
Goiânia 18
Lahore 18
Paris 18
Porto Alegre 18
Hyderabad 16
Poplar 16
Totale 24.573
Nome #
Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story 279
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 270
Abnormalities of glucose metabolism and cardiovascular events in patients with hypertensive nephrosclerosis and mild renal failure 250
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 243
Aldosterone and the heart: from basic research to clinical evidence 208
Abnormalities of insulin receptors in spontaneously hypertensive rats 207
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 206
Aldosterone and Left Ventricular Remodeling 200
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 199
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 187
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 182
Aldosterone and the heart: still an unresolved issue? 181
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 181
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 181
Abnormalities of glucose metabolism in patients with early renal failure 180
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 180
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 175
Aldosterone, Organ Damage, and Dietary Salt 174
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 174
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 172
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 171
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 171
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 168
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 167
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 166
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 166
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 162
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 162
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 162
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 161
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 161
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 160
Diabetes, diabetic complications, and blood pressure targets 160
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 160
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 160
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 159
Insulin Resistance and High Blood Pressure: Mechanistic Insight on the Role of the Kidney 159
Treatment of primary aldosteronism and organ protection 158
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 157
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 157
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 157
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 156
Prohypertensive effect of insulin: possible role of the sympathetic system 155
The emergent cardiovascular risk factors and organ damage in arterial hypertension 155
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 154
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 152
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 152
Cardiovascular outcomes in patients with primary aldosteronism after treatment 152
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 151
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 150
Salt, hypertension, and cardiovascular disease 149
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 149
Spontaneous restoration of sinus rhythm after cardiac surgery 149
The SPARTACUS Trial: Controversies and Unresolved Issues 148
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 147
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 146
Benzodiazepines: an old class of new antihypertensive drugs? 146
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 146
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 146
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 145
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 145
Renal function in primary aldosteronism 144
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 144
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 144
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 143
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 143
Potassium-sparing diuretics in hypertension 141
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 141
Kidney in primary aldosteronism: a key determinant of treatment outcome 141
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 141
Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension 140
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 140
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial 140
Abnormalities of carbohydrate metabolism and cardiovascular disease in patients with early renal failure 139
Glucose metabolism in early renal failure 139
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 138
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 137
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 136
Benign familial macrocytosis 136
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 136
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: The EPATH trial 136
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 135
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 134
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 134
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 134
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 134
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 134
AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY 133
Effects of zofenopril, carvedilol, and lacidipine on alcohol-induced responses in cultured human endothelial cells 133
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 132
Studio del ruolo del sistema simpatico nell’effetto proipertensivo dell’insulina. 131
Hypertension and abnormalities of carbohydrate metabolism: possible role of sympathetic nervous system 131
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 131
Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage 130
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 130
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 130
Endothelial function in patients with non-alcoholic fatty liver disease 129
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 129
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 129
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 128
Totale 15.726
Categoria #
all - tutte 155.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.267


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.474 103 289 98 182 69 88 145 160 26 414 474 426
2022/20232.604 371 118 36 299 234 781 11 166 377 49 88 74
2023/2024870 141 72 55 42 167 93 26 21 105 34 9 105
2024/20255.930 141 420 174 184 116 320 396 383 640 431 1.073 1.652
2025/202611.394 783 1.138 906 1.015 1.668 901 1.490 377 907 1.043 731 435
2026/2027239 239 0 0 0 0 0 0 0 0 0 0 0
Totale 39.913